Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study.
- DOI
- 10.1111/hae.70099
- Published
- 2026 Sep-Oct
- Container
- Haemophilia : the official journal of the World Federation of Hemophilia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/hae.70099,
title = {Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study.},
author = {Holme PA and Poulsen LH and Tueckmantel C and Maas Enriquez M and Alvarez Román MT and De Cristofaro R},
year = {2026},
journal = {Haemophilia : the official journal of the World Federation of Hemophilia},
doi = {10.1111/hae.70099},
url = {https://doi.org/10.1111/hae.70099}
}RIS
TY - JOUR TI - Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study. AU - Holme PA AU - Poulsen LH AU - Tueckmantel C AU - Maas Enriquez M AU - Alvarez Román MT AU - De Cristofaro R PY - 2026 JO - Haemophilia : the official journal of the World Federation of Hemophilia DO - 10.1111/hae.70099 UR - https://doi.org/10.1111/hae.70099 ER -
APA
PA, H., LH, P., C, T., M, M. E., MT, A. R., & R, D. C. (2026). Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study.. Haemophilia : the official journal of the World Federation of Hemophilia. https://doi.org/10.1111/hae.70099
Source records
- pubmed · retrieved 2026-09-26T06:20:13.311Z